ATTENTION ⚠️
In observance of the holidays, Agilent CrossLab/iLab Operations Software Support Help Desk will be closed during U.S. hours on Monday, February 17th, 2025. We will resume regular U.S. support hours on Tuesday, February 18th, 2025. For urgent matters, please add "Urgent" to the ticket/email subject or press "1" when prompted to escalate a call on the iLab Support phone, and we will prioritize those requests first.
The Primary Cell, Biomimetic, and iPSC-derived Cell Models Core B team provides and develops innovative and highly informative models for the three main tissue targets of methamphetamine, cocaine, opioids, cannabis, and HIV – the brain, gut, and peripheral circulation. The models offered can be used to evaluate the impact of drugs of abuse on HIV latency and can also be established with samples derived from persons with Substance Use Disorder and HIV. These models each reflect the diversity of molecular mechanisms governing molecular and cellular responses to drugs and HIV latency in CD4 T cells from the periphery and the gut, and microglial and endothelial cells from the CNS and provide unique opportunities to contrast the effects of substance use in vivo with direct cell biological analyses ex vivo.
- iPSC-derived cortical neurons
- iPSC-derived glutamatergic neurons
- iPSC-derived microglia
- iPSC-derived astrocytes
- Tri-culture (or co-culture) of iPSC-derived neurons, astrocytes, and microglia
Jonathan Karn, Ph.D. | Co-Director | ||
Yoelvis Garcia-Mesa, Ph.D. | Co-Director | 216-368-8892 | yxg146@case.edu |
Alan D. Levine, PhD | Associate director |
Hours | Location |
Monday through Friday (8:00 am to 5:00 pm ET) |
2109 Adelbert Road, School of Medicine, WRT205, Cleveland, Ohio 44106 |
Name | Role | Phone | Location | |
---|---|---|---|---|
Yoelvis Garcia-Mesa, Ph.D. |
Co-Director
|
216-368-8892
|
yoelvis.garcia@case.edu
|
WRT205
|